首页> 外文OA文献 >The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease—chronic kidney disease—mineral and bone disorder: Osteoporosis

【2h】

The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease—chronic kidney disease—mineral and bone disorder: Osteoporosis

机译：雌激素或选择性雌激素受体调节剂对肾脏及其相关疾病（慢性肾脏病），矿物质和骨骼疾病的益处：骨质疏松

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lee Wen-Ling; Cheng Ming-Huei; Tarng Der-Cherng; Yang Wu-Chang; Lee Fa-Kung; Wang Peng-Hui;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease—chronic kidney disease—mineral and bone disorder: Osteoporosis [J] . Wen-Ling Lee, Ming-Huei Cheng, Der-Cherng Tarng, Journal of the Chinese Medical Association: JCMA . 2013,第7期

机译：雌激素或选择性雌激素受体调节剂对肾脏及其相关疾病（慢性肾脏病），矿物质和骨骼疾病的益处：骨质疏松
2. POLYMORPHISM OF ESTROGEN RECEPTORS ALPHA GENE AND BONE MINERAL DENSITY IN WOMEN WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS THERAPY [J] . Mazurenko S. O., Aseev M. V., Enkin A. A., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2017,第Suppla1期

机译：雌激素受体α基因多态性血液透析治疗慢性肾病妇女α基因及骨密度
3. POLYMORPHISM OF ESTROGEN RECEPTORS ALPHA GENE AND BONE MINERAL DENSITY IN WOMEN WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS THERAPY [J] . Mazurenko S. O., Aseev M. V., Enkin A. A., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2017,第Suppla1期

机译：雌激素受体α基因多态性血液透析治疗慢性肾病妇女α基因及骨密度
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Evaluation of a Protocol Change to Improve Screening of Mineral Bone Disorders in Patients With Stage 3 Chronic Kidney Disease [D] . Kelly, Jarena 2011

机译：评估协议变更以改善3期慢性肾脏病患者矿物质骨疾病筛查的评估
6. Can the prophylactic use of raloxifene a selective estrogen-receptor modulator prevent bone mineral loss and fractures in women with diagnosed osteoporosis or vertebral fractures? [O] . Jo Ann Rosenfeld 2000

机译：预防性使用雷洛昔芬（一种选择性的雌激素受体调节剂）可以预防诊断为骨质疏松症或椎骨骨折的女性的骨矿物质流失和骨折吗？
7. The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease—chronic kidney disease—mineral and bone disorder: Osteoporosis [O] . Wen-Ling Lee, Ming-Huei Cheng, Der-Cherng Tarng, 2013

机译：雌激素或选择性雌激素受体调节剂对肾脏及其相关疾病的益处 - 慢性肾脏疾病 - 矿物质和骨骼疾病：骨质疏松症

The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease—chronic kidney disease—mineral and bone disorder: Osteoporosis

著录项

引文网络

相似文献

相关主题

期刊订阅